Narcotic Antagonists
"Narcotic Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents inhibiting the effect of narcotics on the central nervous system.
Descriptor ID |
D009292
|
MeSH Number(s) |
D27.505.696.543 D27.505.696.663.850.512 D27.505.954.427.550
|
Concept/Terms |
Narcotic Antagonists- Narcotic Antagonists
- Antagonists, Narcotic
- Opioid Receptor Antagonists
- Antagonists, Opioid Receptor
- Receptor Antagonists, Opioid
- Opioid Antagonists
- Antagonists, Opioid
|
Below are MeSH descriptors whose meaning is more general than "Narcotic Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Narcotic Antagonists".
This graph shows the total number of publications written about "Narcotic Antagonists" by people in this website by year, and whether "Narcotic Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1981 | 0 | 1 | 1 | 1991 | 0 | 1 | 1 | 1995 | 0 | 1 | 1 | 1997 | 0 | 2 | 2 | 1998 | 1 | 0 | 1 | 1999 | 2 | 0 | 2 | 2001 | 1 | 0 | 1 | 2008 | 1 | 0 | 1 | 2013 | 1 | 0 | 1 | 2015 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Narcotic Antagonists" by people in Profiles.
-
Krupitsky EM, Blokhina EA, Zvartau EE, Verbitskaya VE, Bushara EM, Tiurina AA, Palatkin VY, Yaroslavtseva TS, Burakov AM, Masalov DV, Romanova TN, Grininko AY, Sinha R, Kosten T. [A double-blind randomized placebo-controlled study of the efficacy of the combined treatment with naltrexone and guanfacine for relapse prevention in opiate dependence]. Zh Nevrol Psikhiatr Im S S Korsakova. 2015; 115(10):39-46.
-
Haile CN, Kosten TR. Pharmacotherapy for stimulant-related disorders. Curr Psychiatry Rep. 2013 Nov; 15(11):415.
-
Haile CN, Kosten TA, Kosten TR. Pharmacogenetic treatments for drug addiction: alcohol and opiates. Am J Drug Alcohol Abuse. 2008; 34(4):355-81.
-
Kosten TA, Bombace JC. Ethanol enhances naloxone sensitization and disrupts morphine discrimination--comparison to dizocilpine and pentobarbital: explanation of enhancing acute and attenuating chronic effects. Prog Neuropsychopharmacol Biol Psychiatry. 2001 Aug; 25(6):1283-306.
-
Wang NS, Stewart RB, Meisch RA. Orally delivered methadone as a reinforcer: Effects of the opioid antagonist naloxone. Drug Alcohol Depend. 1999 Jun 01; 55(1-2):79-84.
-
Kosten TA, Haile CN, Jatlow P. Naltrexone and morphine alter the discrimination and plasma levels of ethanol. Behav Pharmacol. 1999 Feb; 10(1):1-13.
-
Boyle AE, Stewart RB, Macenski MJ, Spiga R, Johnson BA, Meisch RA. Effects of acute and chronic doses of naltrexone on ethanol self-administration in rhesus monkeys. Alcohol Clin Exp Res. 1998 Apr; 22(2):359-66.
-
Shoemaker WJ, Kosten TA, Muly SM. Ethanol attenuation of morphine dependence: comparison to dizocilpine. Psychopharmacology (Berl). 1997 Nov; 134(1):83-7.
-
Kulkarni A, McVaugh W, Lawrence B, Pizzini R, Wolinsky I, VanBuren C, Rudolph F, Dafny N. Nutritional supplementation of nucleotides restores opioid CNS-mediated phenomena in mice. Life Sci. 1997; 61(17):1691-6.
-
Kosten TA, DeCaprio JL, Rosen MI. The severity of naloxone-precipitated opiate withdrawal is attenuated by felbamate, a possible glycine antagonist. Neuropsychopharmacology. 1995 Dec; 13(4):323-33.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|